Farzad Abdi-Dezfuli

Dr. Abdi-Dezfuli is currently a Partner at Sarsia Seed Management AS. He has a strong background in preclinical and clinical research with extensive drug development experience from Eli Lilly culminating as Team leader medical, Eli Lilly, Norway. He also brings to the Board several years of experience in commercializing innovative medical/biotech projects from the Sarsia investment group. Dr. Abdi-Dezfuli is/has also served as a Board Member or Observer in several companies including Avexxin, BergenBio, Vaccibody and others.